Home > Research > Researchers > Professor Thomas Jaki > Publications

Professor Thomas Jaki

Professor in Statistics

  1. 2020
  2. Published

    Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs

    Burnett, T., Mozgunov, P., Pallmann, P., Villar, S. S., Wheeler, G. M. & Jaki, T., 19/11/2020, In : BMC Medicine. 18, 1, 21 p., 352.

    Research output: Contribution to journalJournal article

  3. Published

    An information-theoretic approach for selecting arms in clinical trials

    Mozgunov, P. & Jaki, T. F., 10/11/2020, In : Journal of the Royal Statistical Society: Series B (Statistical Methodology). 82, 5, p. 1223-1247 25 p.

    Research output: Contribution to journalJournal article

  4. Forthcoming

    A Benchmark for Dose Finding Studies with Unknown Ordering

    Mozgunov, P., Paoletti, X. & Jaki, T., 9/11/2020, (Accepted/In press) In : Biostatistics.

    Research output: Contribution to journalJournal article

  5. Published

    Using a Dose-Finding Benchmark to Quantify the Loss Incurred by Dichotomisation in Phase II Dose-Ranging Studies

    Mozgunov, P., Jaki, T. & Paoletti, X., 1/11/2020, In : Biometrical Journal. 62, 7, p. 1717-1729 13 p.

    Research output: Contribution to journalJournal article

  6. Published

    Using a dose-finding benchmark to quantify the loss incurred by dichotomization in Phase II dose-ranging studies

    Mozgunov, P., Jaki, T. & Paoletti, X., 1/11/2020, In : Biometrical Journal. 62, 7, p. 1717-1729 13 p.

    Research output: Contribution to journalJournal article

  7. E-pub ahead of print

    Assessing goodness-of-fit for evaluation of dose-proportionality

    Wolfsegger, M. J., Bauer, A., Labes, D., Schütz, H., Vonk, R., Lang, B., Lehr, S., Jaki, T. F., Engl, W. & Hale, M. D., 15/10/2020, In : Pharmaceutical Statistics. 10 p.

    Research output: Contribution to journalJournal article

  8. Published

    A comparison of phase I dose-finding designs in clinical trials with monotonicity assumption violation

    Abbas, R., Rossoni, C., Jaki, T., Paoletti, X. & Mozgunov, P., 1/10/2020, In : Clinical Trials. 17, 5, p. 522-534 13 p.

    Research output: Contribution to journalJournal article

  9. Published

    A surface-free design for phase I dual-agent combination trials

    Mozgunov, P., Gasparini, M. & Jaki, T., 1/10/2020, In : Statistical Methods in Medical Research. 29, 10, p. 3093-3109 17 p.

    Research output: Contribution to journalJournal article

  10. Published

    Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19

    Stallard, N., Hampson, L., Benda, N., Brannath, W., Burnett, T., Friede, T., Kimani, P. K., Koenig, F., Krisam, J., Mozgunov, P., Posch, M., Wason, J., Wassmer, G., Whitehead, J., Williamson, S. F., Zohar, S. & Jaki, T., 1/10/2020, In : Statistics in Biopharmaceutical Research. 12, 4, p. 483-497 15 p.

    Research output: Contribution to journalJournal article

  11. Published

    Endpoints for randomized controlled clinical trials for COVID-19 treatments

    Dodd, L. E., Follmann, D., Wang, J., Koenig, F., Korn, L. L., Schoergenhofer, C., Proschan, M., Hunsberger, S., Bonnett, T., Makowski, M., Belhadi, D., Wang, Y., Cao, B., Mentre, F. & Jaki, T., 1/10/2020, In : Clinical Trials. 17, 5, p. 472-482 11 p.

    Research output: Contribution to journalJournal article

  12. Published

    A Critical Review of Graphics for Subgroup Analyses in Clinical Trials

    Ballarini, N. M., Chiu, Y-D., Koenig, F., Posch, M. & Jaki, T., 1/09/2020, In : Pharmaceutical Statistics. 19, 5, p. 541-560 20 p.

    Research output: Contribution to journalJournal article

  13. Published

    Exposure–response modelling approaches for determining optimal dosing rules in children

    Wadsworth, I., Hampson, L. V., Bornkamp, B. & Jaki, T., 1/09/2020, In : Statistical Methods in Medical Research. 29, 9, p. 2583-2602 20 p.

    Research output: Contribution to journalJournal article

  14. Published
  15. Published

    The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design

    Dimairo, M., Pallmann, P., Wason, J., Todd, S., Jaki, T., Julious, S. A., Mander, A. P., Weir, C. J., Koenig, F., Walton, M. K., Nicholl, J. P., Coates, E., Biggs, K., Hamasaki, T., Proschan, M. A., Scott, J. A., Ando, Y., Hind, D., Altman, D. G. & Group, ACE. C., 17/06/2020, In : Trials. 21, 1, 34 p., 528.

    Research output: Contribution to journalJournal article

  16. Published

    The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design

    Dimairo, M., Pallmann, P., Wason, J., Todd, S., Jaki, T., Julious, S. A., Mander, A. P., Weir, C. J., Koenig, F., Walton, M. K., Nicholl, J. P., Coates, E., Biggs, K., Hamasaki, T., Proschan, M. A., Scott, J. A., Ando, Y., Hind, D., Altman, D. G. & Group, ACE. C., 17/06/2020, In : BMJ. 369, 31 p., m115.

    Research output: Contribution to journalJournal article

  17. Published

    Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: Study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

    Wang, Y., Zhou, F., Zhang, D., Zhao, J., Du, R., Hu, Y., Cheng, Z., Gao, L., Jin, Y., Luo, G., Fu, S., Lu, Q., Du, G., Wang, K., Lu, Y., Fan, G., Zhang, Y., Liu, Y., Ruan, S., Liu, W. & 5 others, Jaki, T., Hayden, F. G., Horby, P. W., Cao, B. & Wang, C., 24/05/2020, In : Trials. 21, 1, 11 p., 422.

    Research output: Contribution to journalJournal article

  18. Published

    Estimation of treatment effects following a sequential trial of multiple treatments

    Whitehead, J., Desai, Y. & Jaki, T., 20/05/2020, In : Statistics in Medicine. 39, 11, p. 1593-1609 17 p.

    Research output: Contribution to journalJournal article

  19. Published

    Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

    Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., Hu, Y., Luo, G., Wang, K., Lu, Y., Li, H., Wang, S., Ruan, S., Yang, C., Mei, C., Ding, D. & 25 others, Wu, F., Tang, X., Ye, X., Ye, Y., Liu, B., Yang, J., Yin, W., Wang, A., Fan, G., Zhou, F., Liu, Z., Gu, X., Xu, J., Shang, L., Zhang, Y., Cao, L., Guo, T., Wan, Y., Qin, H., Jiang, Y., Jaki, T., Hayden, F. G., Horby, P. W., Cao, B. & Wang, C., 16/05/2020, In : The Lancet. p. 1569-1578 10 p.

    Research output: Contribution to journalJournal article

  20. Published

    TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy

    Pushpakom, S., Kolamunnage-Dona, R., Taylor, C., Foster, T., Spowart, C., García-Fiñana, M., Kemp, G. J., Jaki, T., Khoo, S., Williamson, P. & Pirmohamed, M., 15/05/2020, In : Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 70, 10, p. 2062-2072 11 p.

    Research output: Contribution to journalJournal article

  21. Published

    A comparison of stochastic programming methods for portfolio level decision-making

    Graham, E., Jaki, T. & Harbron, C., 1/05/2020, In : Journal of Biopharmaceutical Statistics. 30, 3, p. 405-429 25 p.

    Research output: Contribution to journalJournal article

  22. Published

    Creating a framework for conducting randomized clinical trials during disease outbreaks

    Dean, N. E., Gsell, P-S., Brookmeyer, R., Crawford, F. W., Donnelly, C. A., Ellenberg, S. S., Fleming, T. R., Halloran, E. M., Horby, P., Jaki, T., Krause, P. R., Longini, I. M., Mulangu, S., Muyembe-Tamfum, J-J., Nason, M. C., Smith, P. G., Wang, R., Henao-Restrepo, A. M. & De Gruttola, V., 2/04/2020, In : New England Journal of Medicine. 382, 14, p. 1366-1369 4 p.

    Research output: Contribution to journalEditorial

  23. Published

    A benchmark for dose finding studies with continuous outcomes

    Mozgunov, P., Jaki, T. F. & Paoletti, X., 1/04/2020, In : Biostatistics. 21, 2, p. 189–201 13 p.

    Research output: Contribution to journalJournal article

  24. Published

    Designing and evaluating dose-escalation studies made easy: The MoDEsT web app

    Pallmann, P., Wan, F., Mander, A. P., Wheeler, G. M., Yap, C., Clive, S., Hampson, L. V. & Jaki, T., 1/04/2020, In : Clinical Trials. 17, 2, p. 147-156 10 p.

    Research output: Contribution to journalJournal article

  25. Published

    Repeated measures regression mixture models

    Kim, M., Van Horn, M. L., Jaki, T., Vermunt, J., Feaster, D., Lichstein, K. L., Taylor, D. J., Riedel, B. W. & Bush, A. J., 1/04/2020, In : Behavior Research Methods. 52, 2, p. 591-606 16 p.

    Research output: Contribution to journalJournal article

  26. Published

    Improving safety of the continual reassessment method via a modified allocation rule

    Mozgunov, P. & Jaki, T., 30/03/2020, In : Statistics in Medicine. 39, 7, p. 906-922 17 p.

    Research output: Contribution to journalJournal article

Previous 1 2 3 4 5 6 Next

Back to top